Skip to content

Instantly share code, notes, and snippets.

@ColinW520

ColinW520/GiveToCureCollapsibleHeaderExample.html

Last active December 2, 2015 21:14
Download ZIP

Revisions

  1. ColinW520 revised this gist Dec 2, 2015. 1 changed file with 1 addition and 0 deletions.
    1 change: 1 addition & 0 deletions GiveToCureCollapsibleHeaderExample.html
    View file
    Original file line number Diff line number Diff line change
    @@ -1,3 +1,4 @@
    /* The list name can be anything, just be sure to reference it appropriately with each child element.*/
    <div id="faq_list">
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
  2. ColinW520 revised this gist Dec 2, 2015. 1 changed file with 89 additions and 87 deletions.
    176 changes: 89 additions & 87 deletions GiveToCureCollapsibleHeaderExample.html
    View file
    Original file line number Diff line number Diff line change
    @@ -1,100 +1,102 @@
    <div id="name_this_list">
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div id="faq2">
    <h4 class="content-title-secondary clickable faq_title">
    <a aria-controls="faq2" aria-expanded="false" class="text-info collapsed" data-parent="#faq_list" data-toggle="collapse" href="#faq2Collapse">
    WHO TYPICALLY FUNDS CLINICAL TRIALS? WHY IS THERE A FUNDING GAP?
    </a>
    </h4>
    </div>
    <div aria-labelledby="faq2" class="collapse" id="faq2Collapse">
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div class="faq-content fr-view">
    <p>There are three stages of clinical trials prior to FDA approval – Phase&nbsp;I, II and III. Phase III trials are the most expensive but also most likely&nbsp;to be funded if promising as these programs have generally been&nbsp;in-licensed by a large pharmaceutical company by this stage.</p>
    <p>Phase I and Phase II trials are typically funded by VC firms, private&nbsp;investors, and sometimes sponsored by biotech/pharmaceutical&nbsp;companies. These are highly competitive monies to obtain and often&nbsp;consider many factors beyond pure science. While grants may be&nbsp;available, these are generally on a cost-sharing basis which requires&nbsp;scientists to go out and raise the remainder of funds from other&nbsp;sources. The end result is a bottleneck in funding for promising&nbsp;treatments and a limited number of sources outside traditional&nbsp;industry channels.</p>
    <div id="faq_list">
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div id="faq2">
    <h4 class="content-title-secondary clickable collapsible-header">
    <a aria-controls="faq2" aria-expanded="false" class="text-info collapsed" data-parent="#faq_list" data-toggle="collapse" href="#faq2Collapse">
    WHO TYPICALLY FUNDS CLINICAL TRIALS? WHY IS THERE A FUNDING GAP?
    </a>
    </h4>
    </div>
    <div aria-labelledby="faq2" class="collapse" id="faq2Collapse" aria-expanded="false" style="height: 0px;">
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div class="collapsible-header-content fr-view">
    <p>There are three stages of clinical trials prior to FDA approval – Phase&nbsp;I, II and III. Phase III trials are the most expensive but also most likely&nbsp;to be funded if promising as these programs have generally been&nbsp;in-licensed by a large pharmaceutical company by this stage.</p>
    <p>Phase I and Phase II trials are typically funded by VC firms, private&nbsp;investors, and sometimes sponsored by biotech/pharmaceutical&nbsp;companies. These are highly competitive monies to obtain and often&nbsp;consider many factors beyond pure science. While grants may be&nbsp;available, these are generally on a cost-sharing basis which requires&nbsp;scientists to go out and raise the remainder of funds from other&nbsp;sources. The end result is a bottleneck in funding for promising&nbsp;treatments and a limited number of sources outside traditional&nbsp;industry channels.</p>
    </div>
    </div>
    </div>
    </div>
    </div>
    </div>
    </div>
    </div>
    </div>
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div id="faq3">
    <h4 class="content-title-secondary clickable faq_title">
    <a aria-controls="faq3" aria-expanded="false" class="text-info collapsed" data-parent="#faq_list" data-toggle="collapse" href="#faq3Collapse">
    HOW DO I KNOW WHETHER A CLINICAL TRIAL IS SUCCESSFUL?
    </a>
    </h4>
    </div>
    <div aria-labelledby="faq3" class="collapse" id="faq3Collapse">
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div class="faq-content fr-view">Give To Cure targets Phase I and Phase II clinical trials that typically&nbsp;cost between $5 and $10K5M each.</div>
    </div>
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div id="faq3">
    <h4 class="content-title-secondary clickable collapsible-header">
    <a aria-controls="faq3" aria-expanded="false" class="text-info collapsed" data-parent="#faq_list" data-toggle="collapse" href="#faq3Collapse">
    HOW DO I KNOW WHETHER A CLINICAL TRIAL IS SUCCESSFUL?
    </a>
    </h4>
    </div>
    <div aria-labelledby="faq3" class="collapse" id="faq3Collapse" aria-expanded="false">
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div class="collapsible-header-content fr-view">Give To Cure targets Phase I and Phase II clinical trials that typically&nbsp;cost between $5 and $10K5M each.</div>
    </div>
    </div>
    </div>
    </div>
    </div>
    </div>
    </div>
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div id="faq4">
    <h4 class="content-title-secondary clickable faq_title">
    <a aria-controls="faq4" aria-expanded="false" class="text-info collapsed" data-parent="#faq_list" data-toggle="collapse" href="#faq4Collapse">
    HOW LONG DOES IT TAKE TO KNOW IF WE FOUND A CURE?
    </a>
    </h4>
    </div>
    <div aria-labelledby="faq4" class="collapse" id="faq4Collapse">
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div class="faq-content fr-view">Each clinical trial follows a different FDA approved protocol. Depending on the indication, size and treatment protocol, we should generally&nbsp;know whether the trial was a success between 12 and 36 months.</div>
    </div>
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div id="faq4">
    <h4 class="content-title-secondary clickable collapsible-header">
    <a aria-controls="faq4" aria-expanded="false" class="text-info collapsed" data-parent="#faq_list" data-toggle="collapse" href="#faq4Collapse">
    HOW LONG DOES IT TAKE TO KNOW IF WE FOUND A CURE?
    </a>
    </h4>
    </div>
    <div aria-labelledby="faq4" class="collapse" id="faq4Collapse" aria-expanded="false">
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div class="collapsible-header-content fr-view">Each clinical trial follows a different FDA approved protocol. Depending on the indication, size and treatment protocol, we should generally&nbsp;know whether the trial was a success between 12 and 36 months.</div>
    </div>
    </div>
    </div>
    </div>
    </div>
    </div>
    </div>
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div id="faq5">
    <h4 class="content-title-secondary clickable faq_title">
    <a aria-controls="faq5" aria-expanded="false" class="text-info collapsed" data-parent="#faq_list" data-toggle="collapse" href="#faq5Collapse">
    WHO IS GIVE TO CURE?
    </a>
    </h4>
    </div>
    <div aria-labelledby="faq5" class="collapse" id="faq5Collapse">
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div class="faq-content fr-view">
    <p>Give To Cure was founded by two healthcare entrepreneurs&nbsp;passionate about finding cures and shifting the paradigm shift in the&nbsp;development of life-saving treatments. The need for Give to Cure&nbsp;was identified from within industry. Today, the Give To Cure team&nbsp;comprises of over 20 years experience in healthcare and biotech,&nbsp;regional and national ad campaigns for Fortune 500 companies and&nbsp;start-up and project launches. We are working with some of the&nbsp;world’s leading scientists, business executives, artists, and civil&nbsp;servants – all united by the fact that we all know that we can make a&nbsp;difference together.</p>
    <p>Give to Cure is a 501 (c) 3 non-profit organization. EIN: 46-1885780</p>
    <p>Board Members: Louis G. Reese IV, President; William Kendall, Treasurer; Mei Mei Hu, Secretary.</p>
    <p>Mission Statement: The objects and purposes of the Corporation shall include, but not be limited to: (i) raising awareness of, and educating the public about, diseases for which there are cures or effective treatments that are not available on a wide scale; (ii) creating a worldwide network of supporters dedicated to the fight against such diseases; and (iii) disbursing grants in support of clinical trials for drugs to treat and eradicate such diseases.</p>
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div id="faq5">
    <h4 class="content-title-secondary clickable collapsible-header">
    <a aria-controls="faq5" aria-expanded="false" class="text-info collapsed" data-parent="#faq_list" data-toggle="collapse" href="#faq5Collapse">
    WHO IS GIVE TO CURE?
    </a>
    </h4>
    </div>
    <div aria-labelledby="faq5" class="collapse" id="faq5Collapse" aria-expanded="false">
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div class="collapsible-header-content fr-view">
    <p>Give To Cure was founded by two healthcare entrepreneurs&nbsp;passionate about finding cures and shifting the paradigm shift in the&nbsp;development of life-saving treatments. The need for Give to Cure&nbsp;was identified from within industry. Today, the Give To Cure team&nbsp;comprises of over 20 years experience in healthcare and biotech,&nbsp;regional and national ad campaigns for Fortune 500 companies and&nbsp;start-up and project launches. We are working with some of the&nbsp;world’s leading scientists, business executives, artists, and civil&nbsp;servants – all united by the fact that we all know that we can make a&nbsp;difference together.</p>
    <p>Give to Cure is a 501 (c) 3 non-profit organization. EIN: 46-1885780</p>
    <p>Board Members: Louis G. Reese IV, President; William Kendall, Treasurer; Mei Mei Hu, Secretary.</p>
    <p>Mission Statement: The objects and purposes of the Corporation shall include, but not be limited to: (i) raising awareness of, and educating the public about, diseases for which there are cures or effective treatments that are not available on a wide scale; (ii) creating a worldwide network of supporters dedicated to the fight against such diseases; and (iii) disbursing grants in support of clinical trials for drugs to treat and eradicate such diseases.</p>
    </div>
    </div>
    </div>
    </div>
    </div>
    </div>
    </div>
    </div>
    </div>
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div id="faq1">
    <h4 class="content-title-secondary clickable faq_title">
    <a aria-controls="faq1" aria-expanded="false" class="text-info collapsed" data-parent="#faq_list" data-toggle="collapse" href="#faq1Collapse">
    WHY TARGET CLINICAL TRIALS?
    </a>
    </h4>
    </div>
    <div aria-labelledby="faq1" class="collapse" id="faq1Collapse">
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div class="faq-content fr-view">When Give to Cure targets clinical trials, it is able to maximize the impact of&nbsp;every dollar donated to find a cure. Clinical trials are the last stage of a&nbsp;long and rigorous research process that has typically seen thousands of&nbsp;failures, takes up to 20 years, and costs hundreds of millions of dollars.&nbsp;Treatments that have excelled to this stage, therefore, have the highest&nbsp;probability of success, fastest time to patients and somewhat ironically&nbsp;face the biggest funding bottleneck.<br></div>
    </div>
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div id="faq1">
    <h4 class="content-title-secondary clickable collapsible-header">
    <a aria-controls="faq1" aria-expanded="false" class="text-info collapsed" data-parent="#faq_list" data-toggle="collapse" href="#faq1Collapse">
    WHY TARGET CLINICAL TRIALS?
    </a>
    </h4>
    </div>
    <div aria-labelledby="faq1" class="collapse" id="faq1Collapse" aria-expanded="false">
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div class="collapsible-header-content fr-view">When Give to Cure targets clinical trials, it is able to maximize the impact of&nbsp;every dollar donated to find a cure. Clinical trials are the last stage of a&nbsp;long and rigorous research process that has typically seen thousands of&nbsp;failures, takes up to 20 years, and costs hundreds of millions of dollars.&nbsp;Treatments that have excelled to this stage, therefore, have the highest&nbsp;probability of success, fastest time to patients and somewhat ironically&nbsp;face the biggest funding bottleneck.
    <br>
    </div>
    </div>
    </div>
    </div>
    </div>
    </div>
    </div>
    </div>
    </div>
  3. ColinW520 revised this gist Dec 2, 2015. 1 changed file with 87 additions and 89 deletions.
    176 changes: 87 additions & 89 deletions GiveToCureCollapsibleHeaderExample.html
    View file
    Original file line number Diff line number Diff line change
    @@ -1,102 +1,100 @@
    <div id="faq_list">
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div id="faq2">
    <h4 class="content-title-secondary clickable faq_title">
    <a aria-controls="faq2" aria-expanded="false" class="text-info collapsed" data-parent="#faq_list" data-toggle="collapse" href="#faq2Collapse">
    WHO TYPICALLY FUNDS CLINICAL TRIALS? WHY IS THERE A FUNDING GAP?
    </a>
    </h4>
    </div>
    <div aria-labelledby="2" class="collapse" id="faq2Collapse">
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div class="faq-content fr-view">
    <p>There are three stages of clinical trials prior to FDA approval – Phase&nbsp;I, II and III. Phase III trials are the most expensive but also most likely&nbsp;to be funded if promising as these programs have generally been&nbsp;in-licensed by a large pharmaceutical company by this stage.</p>
    <p>Phase I and Phase II trials are typically funded by VC firms, private&nbsp;investors, and sometimes sponsored by biotech/pharmaceutical&nbsp;companies. These are highly competitive monies to obtain and often&nbsp;consider many factors beyond pure science. While grants may be&nbsp;available, these are generally on a cost-sharing basis which requires&nbsp;scientists to go out and raise the remainder of funds from other&nbsp;sources. The end result is a bottleneck in funding for promising&nbsp;treatments and a limited number of sources outside traditional&nbsp;industry channels.</p>
    </div>
    </div>
    </div>
    <div id="name_this_list">
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div id="faq2">
    <h4 class="content-title-secondary clickable faq_title">
    <a aria-controls="faq2" aria-expanded="false" class="text-info collapsed" data-parent="#faq_list" data-toggle="collapse" href="#faq2Collapse">
    WHO TYPICALLY FUNDS CLINICAL TRIALS? WHY IS THERE A FUNDING GAP?
    </a>
    </h4>
    </div>
    <div aria-labelledby="faq2" class="collapse" id="faq2Collapse">
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div class="faq-content fr-view">
    <p>There are three stages of clinical trials prior to FDA approval – Phase&nbsp;I, II and III. Phase III trials are the most expensive but also most likely&nbsp;to be funded if promising as these programs have generally been&nbsp;in-licensed by a large pharmaceutical company by this stage.</p>
    <p>Phase I and Phase II trials are typically funded by VC firms, private&nbsp;investors, and sometimes sponsored by biotech/pharmaceutical&nbsp;companies. These are highly competitive monies to obtain and often&nbsp;consider many factors beyond pure science. While grants may be&nbsp;available, these are generally on a cost-sharing basis which requires&nbsp;scientists to go out and raise the remainder of funds from other&nbsp;sources. The end result is a bottleneck in funding for promising&nbsp;treatments and a limited number of sources outside traditional&nbsp;industry channels.</p>
    </div>
    </div>
    </div>
    </div>
    </div>
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div id="faq3">
    <h4 class="content-title-secondary clickable faq_title">
    <a aria-controls="faq3" aria-expanded="false" class="text-info collapsed" data-parent="#faq_list" data-toggle="collapse" href="#faq3Collapse">
    HOW DO I KNOW WHETHER A CLINICAL TRIAL IS SUCCESSFUL?
    </a>
    </h4>
    </div>
    <div aria-labelledby="3" class="collapse" id="faq3Collapse">
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div class="faq-content fr-view">Give To Cure targets Phase I and Phase II clinical trials that typically&nbsp;cost between $5 and $10K5M each.</div>
    </div>
    </div>
    </div>
    </div>
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div id="faq3">
    <h4 class="content-title-secondary clickable faq_title">
    <a aria-controls="faq3" aria-expanded="false" class="text-info collapsed" data-parent="#faq_list" data-toggle="collapse" href="#faq3Collapse">
    HOW DO I KNOW WHETHER A CLINICAL TRIAL IS SUCCESSFUL?
    </a>
    </h4>
    </div>
    <div aria-labelledby="faq3" class="collapse" id="faq3Collapse">
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div class="faq-content fr-view">Give To Cure targets Phase I and Phase II clinical trials that typically&nbsp;cost between $5 and $10K5M each.</div>
    </div>
    </div>
    </div>
    </div>
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div id="faq4">
    <h4 class="content-title-secondary clickable faq_title">
    <a aria-controls="faq4" aria-expanded="false" class="text-info collapsed" data-parent="#faq_list" data-toggle="collapse" href="#faq4Collapse">
    HOW LONG DOES IT TAKE TO KNOW IF WE FOUND A CURE?
    </a>
    </h4>
    </div>
    <div aria-labelledby="4" class="collapse" id="faq4Collapse">
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div class="faq-content fr-view">Each clinical trial follows a different FDA approved protocol. Depending on the indication, size and treatment protocol, we should generally&nbsp;know whether the trial was a success between 12 and 36 months.</div>
    </div>
    </div>
    </div>
    </div>
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div id="faq4">
    <h4 class="content-title-secondary clickable faq_title">
    <a aria-controls="faq4" aria-expanded="false" class="text-info collapsed" data-parent="#faq_list" data-toggle="collapse" href="#faq4Collapse">
    HOW LONG DOES IT TAKE TO KNOW IF WE FOUND A CURE?
    </a>
    </h4>
    </div>
    <div aria-labelledby="faq4" class="collapse" id="faq4Collapse">
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div class="faq-content fr-view">Each clinical trial follows a different FDA approved protocol. Depending on the indication, size and treatment protocol, we should generally&nbsp;know whether the trial was a success between 12 and 36 months.</div>
    </div>
    </div>
    </div>
    </div>
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div id="faq5">
    <h4 class="content-title-secondary clickable faq_title">
    <a aria-controls="faq5" aria-expanded="false" class="text-info collapsed" data-parent="#faq_list" data-toggle="collapse" href="#faq5Collapse">
    WHO IS GIVE TO CURE?
    </a>
    </h4>
    </div>
    <div aria-labelledby="5" class="collapse" id="faq5Collapse">
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div class="faq-content fr-view">
    <p>Give To Cure was founded by two healthcare entrepreneurs&nbsp;passionate about finding cures and shifting the paradigm shift in the&nbsp;development of life-saving treatments. The need for Give to Cure&nbsp;was identified from within industry. Today, the Give To Cure team&nbsp;comprises of over 20 years experience in healthcare and biotech,&nbsp;regional and national ad campaigns for Fortune 500 companies and&nbsp;start-up and project launches. We are working with some of the&nbsp;world’s leading scientists, business executives, artists, and civil&nbsp;servants – all united by the fact that we all know that we can make a&nbsp;difference together.</p>
    <p>Give to Cure is a 501 (c) 3 non-profit organization. EIN: 46-1885780</p>
    <p>Board Members: Louis G. Reese IV, President; William Kendall, Treasurer; Mei Mei Hu, Secretary.</p>
    <p>Mission Statement: The objects and purposes of the Corporation shall include, but not be limited to: (i) raising awareness of, and educating the public about, diseases for which there are cures or effective treatments that are not available on a wide scale; (ii) creating a worldwide network of supporters dedicated to the fight against such diseases; and (iii) disbursing grants in support of clinical trials for drugs to treat and eradicate such diseases.</p>
    </div>
    </div>
    </div>
    </div>
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div id="faq5">
    <h4 class="content-title-secondary clickable faq_title">
    <a aria-controls="faq5" aria-expanded="false" class="text-info collapsed" data-parent="#faq_list" data-toggle="collapse" href="#faq5Collapse">
    WHO IS GIVE TO CURE?
    </a>
    </h4>
    </div>
    <div aria-labelledby="faq5" class="collapse" id="faq5Collapse">
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div class="faq-content fr-view">
    <p>Give To Cure was founded by two healthcare entrepreneurs&nbsp;passionate about finding cures and shifting the paradigm shift in the&nbsp;development of life-saving treatments. The need for Give to Cure&nbsp;was identified from within industry. Today, the Give To Cure team&nbsp;comprises of over 20 years experience in healthcare and biotech,&nbsp;regional and national ad campaigns for Fortune 500 companies and&nbsp;start-up and project launches. We are working with some of the&nbsp;world’s leading scientists, business executives, artists, and civil&nbsp;servants – all united by the fact that we all know that we can make a&nbsp;difference together.</p>
    <p>Give to Cure is a 501 (c) 3 non-profit organization. EIN: 46-1885780</p>
    <p>Board Members: Louis G. Reese IV, President; William Kendall, Treasurer; Mei Mei Hu, Secretary.</p>
    <p>Mission Statement: The objects and purposes of the Corporation shall include, but not be limited to: (i) raising awareness of, and educating the public about, diseases for which there are cures or effective treatments that are not available on a wide scale; (ii) creating a worldwide network of supporters dedicated to the fight against such diseases; and (iii) disbursing grants in support of clinical trials for drugs to treat and eradicate such diseases.</p>
    </div>
    </div>
    </div>
    </div>
    </div>
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div id="faq1">
    <h4 class="content-title-secondary clickable faq_title">
    <a aria-controls="faq1" aria-expanded="false" class="text-info collapsed" data-parent="#faq_list" data-toggle="collapse" href="#faq1Collapse">
    WHY TARGET CLINICAL TRIALS?
    </a>
    </h4>
    </div>
    <div aria-labelledby="1" class="collapse" id="faq1Collapse">
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div class="faq-content fr-view">When Give to Cure targets clinical trials, it is able to maximize the impact of&nbsp;every dollar donated to find a cure. Clinical trials are the last stage of a&nbsp;long and rigorous research process that has typically seen thousands of&nbsp;failures, takes up to 20 years, and costs hundreds of millions of dollars.&nbsp;Treatments that have excelled to this stage, therefore, have the highest&nbsp;probability of success, fastest time to patients and somewhat ironically&nbsp;face the biggest funding bottleneck.
    <br>
    </div>
    </div>
    </div>
    </div>
    </div>
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div id="faq1">
    <h4 class="content-title-secondary clickable faq_title">
    <a aria-controls="faq1" aria-expanded="false" class="text-info collapsed" data-parent="#faq_list" data-toggle="collapse" href="#faq1Collapse">
    WHY TARGET CLINICAL TRIALS?
    </a>
    </h4>
    </div>
    <div aria-labelledby="faq1" class="collapse" id="faq1Collapse">
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div class="faq-content fr-view">When Give to Cure targets clinical trials, it is able to maximize the impact of&nbsp;every dollar donated to find a cure. Clinical trials are the last stage of a&nbsp;long and rigorous research process that has typically seen thousands of&nbsp;failures, takes up to 20 years, and costs hundreds of millions of dollars.&nbsp;Treatments that have excelled to this stage, therefore, have the highest&nbsp;probability of success, fastest time to patients and somewhat ironically&nbsp;face the biggest funding bottleneck.<br></div>
    </div>
    </div>
    </div>
    </div>
    </div>
    </div>
  4. ColinW520 revised this gist Dec 2, 2015. 1 changed file with 80 additions and 70 deletions.
    150 changes: 80 additions & 70 deletions GiveToCureCollapsibleHeaderExample.html
    View file
    Original file line number Diff line number Diff line change
    @@ -1,92 +1,102 @@
    <div id="faq_list">
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div id="faq2">
    <h4 class="content-title-secondary clickable faq_title">
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div id="faq2">
    <h4 class="content-title-secondary clickable faq_title">
    <a aria-controls="faq2" aria-expanded="false" class="text-info collapsed" data-parent="#faq_list" data-toggle="collapse" href="#faq2Collapse">
    WHO TYPICALLY FUNDS CLINICAL TRIALS? WHY IS THERE A FUNDING GAP?
    </a>
    </h4>
    </div>
    <div aria-labelledby="2" class="collapse" id="faq2Collapse">
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div class="faq-content fr-view"><p>There are three stages of clinical trials prior to FDA approval – Phase&nbsp;I, II and III. Phase III trials are the most expensive but also most likely&nbsp;to be funded if promising as these programs have generally been&nbsp;in-licensed by a large pharmaceutical company by this stage.</p><p>Phase I and Phase II trials are typically funded by VC firms, private&nbsp;investors, and sometimes sponsored by biotech/pharmaceutical&nbsp;companies. These are highly competitive monies to obtain and often&nbsp;consider many factors beyond pure science. While grants may be&nbsp;available, these are generally on a cost-sharing basis which requires&nbsp;scientists to go out and raise the remainder of funds from other&nbsp;sources. The end result is a bottleneck in funding for promising&nbsp;treatments and a limited number of sources outside traditional&nbsp;industry channels.</p></div>
    </div>
    </div>
    </div>
    </div>
    </div>
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div id="faq3">
    <h4 class="content-title-secondary clickable faq_title">
    </div>
    <div aria-labelledby="2" class="collapse" id="faq2Collapse">
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div class="faq-content fr-view">
    <p>There are three stages of clinical trials prior to FDA approval – Phase&nbsp;I, II and III. Phase III trials are the most expensive but also most likely&nbsp;to be funded if promising as these programs have generally been&nbsp;in-licensed by a large pharmaceutical company by this stage.</p>
    <p>Phase I and Phase II trials are typically funded by VC firms, private&nbsp;investors, and sometimes sponsored by biotech/pharmaceutical&nbsp;companies. These are highly competitive monies to obtain and often&nbsp;consider many factors beyond pure science. While grants may be&nbsp;available, these are generally on a cost-sharing basis which requires&nbsp;scientists to go out and raise the remainder of funds from other&nbsp;sources. The end result is a bottleneck in funding for promising&nbsp;treatments and a limited number of sources outside traditional&nbsp;industry channels.</p>
    </div>
    </div>
    </div>
    </div>
    </div>
    </div>
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div id="faq3">
    <h4 class="content-title-secondary clickable faq_title">
    <a aria-controls="faq3" aria-expanded="false" class="text-info collapsed" data-parent="#faq_list" data-toggle="collapse" href="#faq3Collapse">
    HOW DO I KNOW WHETHER A CLINICAL TRIAL IS SUCCESSFUL?
    </a>
    </h4>
    </div>
    <div aria-labelledby="3" class="collapse" id="faq3Collapse">
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div class="faq-content fr-view">Give To Cure targets Phase I and Phase II clinical trials that typically&nbsp;cost between $5 and $10K5M each.</div>
    </div>
    </div>
    </div>
    </div>
    </div>
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div id="faq4">
    <h4 class="content-title-secondary clickable faq_title">
    </div>
    <div aria-labelledby="3" class="collapse" id="faq3Collapse">
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div class="faq-content fr-view">Give To Cure targets Phase I and Phase II clinical trials that typically&nbsp;cost between $5 and $10K5M each.</div>
    </div>
    </div>
    </div>
    </div>
    </div>
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div id="faq4">
    <h4 class="content-title-secondary clickable faq_title">
    <a aria-controls="faq4" aria-expanded="false" class="text-info collapsed" data-parent="#faq_list" data-toggle="collapse" href="#faq4Collapse">
    HOW LONG DOES IT TAKE TO KNOW IF WE FOUND A CURE?
    </a>
    </h4>
    </div>
    <div aria-labelledby="4" class="collapse" id="faq4Collapse">
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div class="faq-content fr-view">Each clinical trial follows a different FDA approved protocol. Depending on the indication, size and treatment protocol, we should generally&nbsp;know whether the trial was a success between 12 and 36 months.</div>
    </div>
    </div>
    </div>
    </div>
    </div>
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div id="faq5">
    <h4 class="content-title-secondary clickable faq_title">
    </div>
    <div aria-labelledby="4" class="collapse" id="faq4Collapse">
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div class="faq-content fr-view">Each clinical trial follows a different FDA approved protocol. Depending on the indication, size and treatment protocol, we should generally&nbsp;know whether the trial was a success between 12 and 36 months.</div>
    </div>
    </div>
    </div>
    </div>
    </div>
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div id="faq5">
    <h4 class="content-title-secondary clickable faq_title">
    <a aria-controls="faq5" aria-expanded="false" class="text-info collapsed" data-parent="#faq_list" data-toggle="collapse" href="#faq5Collapse">
    WHO IS GIVE TO CURE?
    </a>
    </h4>
    </div>
    <div aria-labelledby="5" class="collapse" id="faq5Collapse">
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div class="faq-content fr-view"><p>Give To Cure was founded by two healthcare entrepreneurs&nbsp;passionate about finding cures and shifting the paradigm shift in the&nbsp;development of life-saving treatments. The need for Give to Cure&nbsp;was identified from within industry. Today, the Give To Cure team&nbsp;comprises of over 20 years experience in healthcare and biotech,&nbsp;regional and national ad campaigns for Fortune 500 companies and&nbsp;start-up and project launches. We are working with some of the&nbsp;world’s leading scientists, business executives, artists, and civil&nbsp;servants – all united by the fact that we all know that we can make a&nbsp;difference together.</p><p>Give to Cure is a 501 (c) 3 non-profit organization. EIN: 46-1885780</p><p>Board Members: Louis G. Reese IV, President; William Kendall, Treasurer; Mei Mei Hu, Secretary.</p><p>Mission Statement: The objects and purposes of the Corporation shall include, but not be limited to: (i) raising awareness of, and educating the public about, diseases for which there are cures or effective treatments that are not available on a wide scale; (ii) creating a worldwide network of supporters dedicated to the fight against such diseases; and (iii) disbursing grants in support of clinical trials for drugs to treat and eradicate such diseases.</p></div>
    </div>
    </div>
    </div>
    </div>
    </div>
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div id="faq1">
    <h4 class="content-title-secondary clickable faq_title">
    </div>
    <div aria-labelledby="5" class="collapse" id="faq5Collapse">
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div class="faq-content fr-view">
    <p>Give To Cure was founded by two healthcare entrepreneurs&nbsp;passionate about finding cures and shifting the paradigm shift in the&nbsp;development of life-saving treatments. The need for Give to Cure&nbsp;was identified from within industry. Today, the Give To Cure team&nbsp;comprises of over 20 years experience in healthcare and biotech,&nbsp;regional and national ad campaigns for Fortune 500 companies and&nbsp;start-up and project launches. We are working with some of the&nbsp;world’s leading scientists, business executives, artists, and civil&nbsp;servants – all united by the fact that we all know that we can make a&nbsp;difference together.</p>
    <p>Give to Cure is a 501 (c) 3 non-profit organization. EIN: 46-1885780</p>
    <p>Board Members: Louis G. Reese IV, President; William Kendall, Treasurer; Mei Mei Hu, Secretary.</p>
    <p>Mission Statement: The objects and purposes of the Corporation shall include, but not be limited to: (i) raising awareness of, and educating the public about, diseases for which there are cures or effective treatments that are not available on a wide scale; (ii) creating a worldwide network of supporters dedicated to the fight against such diseases; and (iii) disbursing grants in support of clinical trials for drugs to treat and eradicate such diseases.</p>
    </div>
    </div>
    </div>
    </div>
    </div>
    </div>
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div id="faq1">
    <h4 class="content-title-secondary clickable faq_title">
    <a aria-controls="faq1" aria-expanded="false" class="text-info collapsed" data-parent="#faq_list" data-toggle="collapse" href="#faq1Collapse">
    WHY TARGET CLINICAL TRIALS?
    </a>
    </h4>
    </div>
    <div aria-labelledby="1" class="collapse" id="faq1Collapse">
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div class="faq-content fr-view">When Give to Cure targets clinical trials, it is able to maximize the impact of&nbsp;every dollar donated to find a cure. Clinical trials are the last stage of a&nbsp;long and rigorous research process that has typically seen thousands of&nbsp;failures, takes up to 20 years, and costs hundreds of millions of dollars.&nbsp;Treatments that have excelled to this stage, therefore, have the highest&nbsp;probability of success, fastest time to patients and somewhat ironically&nbsp;face the biggest funding bottleneck.<br></div>
    </div>
    </div>
    </div>
    </div>
    </div>
    </div>
    <div aria-labelledby="1" class="collapse" id="faq1Collapse">
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div class="faq-content fr-view">When Give to Cure targets clinical trials, it is able to maximize the impact of&nbsp;every dollar donated to find a cure. Clinical trials are the last stage of a&nbsp;long and rigorous research process that has typically seen thousands of&nbsp;failures, takes up to 20 years, and costs hundreds of millions of dollars.&nbsp;Treatments that have excelled to this stage, therefore, have the highest&nbsp;probability of success, fastest time to patients and somewhat ironically&nbsp;face the biggest funding bottleneck.
    <br>
    </div>
    </div>
    </div>
    </div>
    </div>
    </div>
    </div>
  5. ColinW520 revised this gist Dec 2, 2015. 1 changed file with 90 additions and 5 deletions.
    95 changes: 90 additions & 5 deletions GiveToCureCollapsibleHeaderExample.html
    View file
    Original file line number Diff line number Diff line change
    @@ -1,7 +1,92 @@
    <div id="faq_list">
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div id="faq2">
    <h4 class="content-title-secondary clickable faq_title">
    <a aria-controls="faq2" aria-expanded="false" class="text-info collapsed" data-parent="#faq_list" data-toggle="collapse" href="#faq2Collapse">
    WHO TYPICALLY FUNDS CLINICAL TRIALS? WHY IS THERE A FUNDING GAP?
    </a>
    </h4>
    <h4 class="content-title-secondary clickable faq_title">
    <a aria-controls="faq2" aria-expanded="false" class="text-info collapsed" data-parent="#faq_list" data-toggle="collapse" href="#faq2Collapse">
    WHO TYPICALLY FUNDS CLINICAL TRIALS? WHY IS THERE A FUNDING GAP?
    </a>
    </h4>
    </div>
    <div aria-labelledby="2" class="collapse" id="faq2Collapse">
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div class="faq-content fr-view"><p>There are three stages of clinical trials prior to FDA approval – Phase&nbsp;I, II and III. Phase III trials are the most expensive but also most likely&nbsp;to be funded if promising as these programs have generally been&nbsp;in-licensed by a large pharmaceutical company by this stage.</p><p>Phase I and Phase II trials are typically funded by VC firms, private&nbsp;investors, and sometimes sponsored by biotech/pharmaceutical&nbsp;companies. These are highly competitive monies to obtain and often&nbsp;consider many factors beyond pure science. While grants may be&nbsp;available, these are generally on a cost-sharing basis which requires&nbsp;scientists to go out and raise the remainder of funds from other&nbsp;sources. The end result is a bottleneck in funding for promising&nbsp;treatments and a limited number of sources outside traditional&nbsp;industry channels.</p></div>
    </div>
    </div>
    </div>
    </div>
    </div>
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div id="faq3">
    <h4 class="content-title-secondary clickable faq_title">
    <a aria-controls="faq3" aria-expanded="false" class="text-info collapsed" data-parent="#faq_list" data-toggle="collapse" href="#faq3Collapse">
    HOW DO I KNOW WHETHER A CLINICAL TRIAL IS SUCCESSFUL?
    </a>
    </h4>
    </div>
    <div aria-labelledby="3" class="collapse" id="faq3Collapse">
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div class="faq-content fr-view">Give To Cure targets Phase I and Phase II clinical trials that typically&nbsp;cost between $5 and $10K5M each.</div>
    </div>
    </div>
    </div>
    </div>
    </div>
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div id="faq4">
    <h4 class="content-title-secondary clickable faq_title">
    <a aria-controls="faq4" aria-expanded="false" class="text-info collapsed" data-parent="#faq_list" data-toggle="collapse" href="#faq4Collapse">
    HOW LONG DOES IT TAKE TO KNOW IF WE FOUND A CURE?
    </a>
    </h4>
    </div>
    <div aria-labelledby="4" class="collapse" id="faq4Collapse">
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div class="faq-content fr-view">Each clinical trial follows a different FDA approved protocol. Depending on the indication, size and treatment protocol, we should generally&nbsp;know whether the trial was a success between 12 and 36 months.</div>
    </div>
    </div>
    </div>
    </div>
    </div>
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div id="faq5">
    <h4 class="content-title-secondary clickable faq_title">
    <a aria-controls="faq5" aria-expanded="false" class="text-info collapsed" data-parent="#faq_list" data-toggle="collapse" href="#faq5Collapse">
    WHO IS GIVE TO CURE?
    </a>
    </h4>
    </div>
    <div aria-labelledby="5" class="collapse" id="faq5Collapse">
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div class="faq-content fr-view"><p>Give To Cure was founded by two healthcare entrepreneurs&nbsp;passionate about finding cures and shifting the paradigm shift in the&nbsp;development of life-saving treatments. The need for Give to Cure&nbsp;was identified from within industry. Today, the Give To Cure team&nbsp;comprises of over 20 years experience in healthcare and biotech,&nbsp;regional and national ad campaigns for Fortune 500 companies and&nbsp;start-up and project launches. We are working with some of the&nbsp;world’s leading scientists, business executives, artists, and civil&nbsp;servants – all united by the fact that we all know that we can make a&nbsp;difference together.</p><p>Give to Cure is a 501 (c) 3 non-profit organization. EIN: 46-1885780</p><p>Board Members: Louis G. Reese IV, President; William Kendall, Treasurer; Mei Mei Hu, Secretary.</p><p>Mission Statement: The objects and purposes of the Corporation shall include, but not be limited to: (i) raising awareness of, and educating the public about, diseases for which there are cures or effective treatments that are not available on a wide scale; (ii) creating a worldwide network of supporters dedicated to the fight against such diseases; and (iii) disbursing grants in support of clinical trials for drugs to treat and eradicate such diseases.</p></div>
    </div>
    </div>
    </div>
    </div>
    </div>
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div id="faq1">
    <h4 class="content-title-secondary clickable faq_title">
    <a aria-controls="faq1" aria-expanded="false" class="text-info collapsed" data-parent="#faq_list" data-toggle="collapse" href="#faq1Collapse">
    WHY TARGET CLINICAL TRIALS?
    </a>
    </h4>
    </div>
    <div aria-labelledby="1" class="collapse" id="faq1Collapse">
    <div class="row">
    <div class="col-sm-12 col-md-12 col-lg-12 col-xs-12">
    <div class="faq-content fr-view">When Give to Cure targets clinical trials, it is able to maximize the impact of&nbsp;every dollar donated to find a cure. Clinical trials are the last stage of a&nbsp;long and rigorous research process that has typically seen thousands of&nbsp;failures, takes up to 20 years, and costs hundreds of millions of dollars.&nbsp;Treatments that have excelled to this stage, therefore, have the highest&nbsp;probability of success, fastest time to patients and somewhat ironically&nbsp;face the biggest funding bottleneck.<br></div>
    </div>
    </div>
    </div>
    </div>
    </div>
    </div>
  6. ColinW520 renamed this gist Dec 2, 2015. 1 changed file with 0 additions and 0 deletions.
    0 gistfile1.txt → GiveToCureCollapsibleHeaderExample.html
    View file
    File renamed without changes.
  7. ColinW520 created this gist Dec 2, 2015.
    7 changes: 7 additions & 0 deletions gistfile1.txt
    View file
    Original file line number Diff line number Diff line change
    @@ -0,0 +1,7 @@
    <div id="faq2">
    <h4 class="content-title-secondary clickable faq_title">
    <a aria-controls="faq2" aria-expanded="false" class="text-info collapsed" data-parent="#faq_list" data-toggle="collapse" href="#faq2Collapse">
    WHO TYPICALLY FUNDS CLINICAL TRIALS? WHY IS THERE A FUNDING GAP?
    </a>
    </h4>
    </div>